4//SEC Filing
Orlinger Klaus 4
Accession 0001104659-22-010541
CIK 0001760542other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 8:52 PM ET
Size
7.0 KB
Accession
0001104659-22-010541
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Common Stock
2022-02-01$3.00/sh+9,188$27,564→ 10,404 total - Award
Stock Option (Right to Buy)
2022-02-01$3.00/sh+12,654$37,962→ 12,654 totalExercise: $1.50Exp: 2032-01-31→ Common Stock (12,654 underlying)
Footnotes (2)
- [F1]The Reporting Person was awarded 9,188 unrestricted shares of common stock as a portion of their base salary for the six month ending June 30, 2022.
- [F2]This stock option is fully vested.
Documents
Issuer
HOOKIPA Pharma Inc.
CIK 0001760542
Entity typeother
Related Parties
1- filerCIK 0001768432
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 8:52 PM ET
- Size
- 7.0 KB